Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S., Lai, F., Rosas, H. D., Lee, J. H., … Xu, X. (2023). Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer’s disease: a cross-sectional study. The Lancet Neurology, 22(1), 55–65. https://doi.org/10.1016/s1474-4422(22)00408-2
Authors:
Anna H Boerwinkle
Brian A Gordon
Julie Wisch
Shaney Flores
Rachel L Henson
Omar H Butt
Nicole McKay
Charles D Chen
Tammie L S Benzinger
Anne M Fagan
Benjamin L Handen
Bradley T Christian
Elizabeth Head
Mark Mapstone
Michael S Rafii
Sid O'Bryant
Florence Lai
H Diana Rosas
Joseph H Lee
Wayne Silverman
Adam M Brickman
Jasmeer P Chhatwal
Carlos Cruchaga
Richard J Perrin
Chengjie Xiong
Jason Hassenstab
Eric McDade
Randall J Bateman
Beau M Ances
Affiliated Authors:
Joseph H Lee
Adam M Brickman
Columbia Affiliation:
Subjects:
Alzheimer Disease (MeSH)
Amyloid beta-Peptides (MeSH)
Down Syndrome (MeSH)
Cerebral Cortex (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/s1474-4422(22)00408-2
PMID:
36517172
DOI:
10.1016/s1474-4422(22)00408-2
Journal:
Lancet Neurology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: